BioAtla, Inc. 8-K

What Happened

• BioAtla, Inc. filed a Certificate of Merger with the Delaware Secretary of State on April 2, 2026, confirming a merger that will become effective April 6, 2026 at 12:01 a.m. Eastern Time.
• Under the merger, BA Merger Sub, Inc. (a wholly owned subsidiary) will merge into BioAtla, with BioAtla surviving. At the Effective Time, every 50 shares of BioAtla common stock issued and outstanding (or held as treasury stock) will be converted into one share of common stock of the surviving corporation (a 50-for-1 consolidation).

Key Details

• Certificate of Merger filed: April 2, 2026; Effective Time: April 6, 2026 at 12:01 a.m. ET.
• Merger structure: BA Merger Sub, Inc. merges into BioAtla; BioAtla survives.
• Share conversion: each 50 existing shares → 1 share of the surviving company (applies to issued, outstanding, and treasury shares).
• The merger implements the previously announced Agreement and Plan of Merger (adopted Jan 30, 2026, as amended).

Why It Matters

• This transaction materially reduces the company’s number of outstanding shares by a factor of 50 (a 50-for-1 share consolidation effected through the merger). That changes the share count and the per-share basis for investors; holdings will be automatically converted at the stated ratio.
• The filing formalizes the legal steps for the transaction to take effect and informs shareholders and the market of the timing and mechanics. Investors should look for follow-up notices from the company or their brokers about how the conversion will appear in accounts and any related timing for trading adjustments.